THERAPEUTICS
Review: reduction in resting heart rate after taking β-blockers or calcium-channel blockers reduce mortality and morbidity after MI
| The first 150 words of the full text of this article appear below. |
M Cucherat
Dr M Cucherat, Universite Lyon, Lyon, France; mcu@upcl.univ-lyon.fr
QUESTION
In patients who have had a myocardial infarction (MI), do reductions in resting heart rate (HR) after treatment with β-blockers (BBs) or calcium-channel blockers (CCBs) reduce mortality and morbidity?
REVIEW SCOPE:
Included studies evaluated BBs or CCBs in patients with a history of MI followed for
1 year with <10% attrition. Outcomes were relation between resting HR reduction and all-cause mortality, cardiac death, cardiovascular (CV) death, sudden death, non-fatal MI recurrence, fatal and non-fatal MI, and cardiac events.
REVIEW METHODS:
Medline and EMBASE (1966 to January 2006), Cochrane Controlled Trials Register (Issue 4, 2005), reference lists, and conference proceedings were searched for randomised, double-blind, placebo controlled trials (RCTs). 25 RCTs (n = 30 904; mean age range 48-81 y based on 14 RCTs) met the selection criteria: 21 RCTs evaluated BBs and 4 RCTs evaluated CCBs; 17 RCTs reported changes in resting HR; and
Geisinger Clinic, Danville, Pennsylvania, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
